Pulmonary injury after intestinal ischemia and reperfusion injury: effects of treatment with lexipafant, a PAF antagonist

Detalles Bibliográficos
Autores principales: Börjesson, A, Wang, XD, Andersson, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 1998
Materias:
Meeting Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301258/
http://dx.doi.org/10.1186/cc146
_version_ 1782226466451226624
author Börjesson, A
Wang, XD
Andersson, R
author_facet Börjesson, A
Wang, XD
Andersson, R
author_sort Börjesson, A
collection PubMed
description
format Online
Article
Text
id pubmed-3301258
institution National Center for Biotechnology Information
language English
publishDate 1998
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33012582012-03-14 Pulmonary injury after intestinal ischemia and reperfusion injury: effects of treatment with lexipafant, a PAF antagonist Börjesson, A Wang, XD Andersson, R Crit Care Meeting Abstract BioMed Central 1998 1998-03-01 /pmc/articles/PMC3301258/ http://dx.doi.org/10.1186/cc146 Text en Copyright ©1998 Current Science Ltd
spellingShingle Meeting Abstract
Börjesson, A
Wang, XD
Andersson, R
Pulmonary injury after intestinal ischemia and reperfusion injury: effects of treatment with lexipafant, a PAF antagonist
title Pulmonary injury after intestinal ischemia and reperfusion injury: effects of treatment with lexipafant, a PAF antagonist
title_full Pulmonary injury after intestinal ischemia and reperfusion injury: effects of treatment with lexipafant, a PAF antagonist
title_fullStr Pulmonary injury after intestinal ischemia and reperfusion injury: effects of treatment with lexipafant, a PAF antagonist
title_full_unstemmed Pulmonary injury after intestinal ischemia and reperfusion injury: effects of treatment with lexipafant, a PAF antagonist
title_short Pulmonary injury after intestinal ischemia and reperfusion injury: effects of treatment with lexipafant, a PAF antagonist
title_sort pulmonary injury after intestinal ischemia and reperfusion injury: effects of treatment with lexipafant, a paf antagonist
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301258/
http://dx.doi.org/10.1186/cc146
work_keys_str_mv AT borjessona pulmonaryinjuryafterintestinalischemiaandreperfusioninjuryeffectsoftreatmentwithlexipafantapafantagonist
AT wangxd pulmonaryinjuryafterintestinalischemiaandreperfusioninjuryeffectsoftreatmentwithlexipafantapafantagonist
AT anderssonr pulmonaryinjuryafterintestinalischemiaandreperfusioninjuryeffectsoftreatmentwithlexipafantapafantagonist

Ejemplares similares